SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-149424
Filing Date
2023-05-19
Accepted
2023-05-19 16:45:54
Documents
12
Period of Report
2023-05-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d501370d8k.htm   iXBRL 8-K 29707
  Complete submission text file 0001193125-23-149424.txt   158596

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA elym-20230518.xsd EX-101.SCH 2839
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE elym-20230518_lab.xml EX-101.LAB 19501
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elym-20230518_pre.xml EX-101.PRE 12149
6 EXTRACTED XBRL INSTANCE DOCUMENT d501370d8k_htm.xml XML 3597
Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 877-354-3689
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40708 | Film No.: 23941055
SIC: 2834 Pharmaceutical Preparations